ARCHITECTURE & DESIGN
The Paterson Replacement Project at The Christie’s Withington site in Manchester. Above left: A CGI image of the exterior of the Paterson Replacement Project. Above right: A 3D axonometric diagram; the new building will be part seven and part 10 storeys high (plus basement). Left: The Ground Floor Level provides the main entrance and the reception to the research centre, and will also act as a hub for collaboration, via engagement spaces and a publicly accessible café.
benefits from a huge central lightwell, and access to an outdoor Winter Garden. A biobank allows collection of a variety
of cancer types, both common and rare, giving scientists the best snapshot of the current cancer landscape. This increases knowledge and understanding which will lead to new and improved treatment options for the future. The pharmacy department is located within a purpose-built facility that houses five isolators and a gene therapy isolator. The core business of the department is the production of sterile chemotherapy products for patients at the Centre, satellite clinics, and private patients. Other services include the organisation and management of clinical trials, such as the self-medication service and a ward pharmacy service. Last year, a Merseyside man became
the first in the UK to receive a new cancer vaccine designed to help his immune system ward off head and neck cancer permanently. The clinical research team at The Clatterbridge Cancer Centre had given the patient an injection of a therapy tailor- made to his personal DNA, and designed to help his own immune system ward off cancer permanently.
Paterson Replacement Project, The Christie, Manchester This 26,500 m2
which housed the majority of the Cancer Research UK Manchester Institute (CRUK MI), caught fire in 2017, resulting in significant structural damage, as well as the loss of years of research, and hundreds of thousands of pounds of equipment. Following feasibility assessments, it was announced that repair and refurbishment of the Paterson Building would not be viable, and that the building would be demolished and replaced with a modern facility. CRUK MI temporarily relocated to Alderley Park in Cheshire, one of the largest life science communities in Europe, occupying laboratory and office space in an agreement that will see scientists conduct research and development activity from a site that already has an international reputation for breakthroughs in oncology.
facility is currently under construction. The Paterson Building, 28 Health Estate Journal January 2023
Aspiration for a world-class facility The aspiration for the Paterson Replacement Project (PRP) is for the delivery of a world-class research facility on The Christie Withington site, which is is the home to The Christie NHS Foundation Trust, the Oglesby Cancer Research Building (formally Manchester Cancer Research Centre (MCRC)), the CRUK Manchester Institute, and the Maggie’s Centre. The breadth of the activity will be expanded, with specific public and patient- focused themes to work on prevention,
early identification of cancer, and living with cancer, which will accelerate progress towards realising the ambition to become a ‘Top 5’ translational cancer research centre in the world by 2025. The new building will be part seven and part 10 storeys high (plus basement), and will enable multiple teams engaged in the ‘research pipeline’ that leads from discovery to clinical applications to be co-located into a single facility, and physically linked to a world-leading cancer hospital with ease of access to patients. The Ground Floor Level provides the main entrance and the reception to the research centre. It will also act as a hub for collaboration, via engagement spaces and a publicly accessible cafe, which will promote interactions between scientists, clinicians, and allied medical professionals. This level will showcase the research and development being undertaken by the Christie, and be an open, welcoming, and accessible facility, which encourages public engagement and community outreach.
Integration with other research facilities Before the fire The Manchester Centre for Biomarker Sciences was to be provided as an extension to the Oglesby Cancer Research Building, but the PRP provided the opportunity to physically
Images courtesy of BDP
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73
